⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 14, 2024British Journal of PharmacologyOpen Access

Anti‐chitinase‐3‐like 1 antibody attenuated atopic dermatitis‐like skin inflammation through inhibition of STAT3‐dependent CXCL8 expression

Ji Eun Yu Seong Hee Jeon Min Ji Kim Dae Hwan Kim Ja Keun Koo Tae Hun Kim Bongcheol Kim Ji Yong Yoon Young‐soo Lim So Ra Park In Jun Yeo Jaesuk Yun Dong Ju Son Sang‐Bae Han Yong Sun Lee Jin Tae Hong

View Full Paper

Ask AI

Bookmark

Share

Abstract

Chitinase-3-like 1 (CHI3L1) causes skin inflammation in the progression of atopic dermatitis. We investigated if anti-CHI3L1 antibody could prevent the development of atopic dermatitis and its mechanisms of action.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yu et al. (2024) studied this question.

synapsesocial.com/papers/68e6a28cb6db6435876260df https://doi.org/10.1111/bph.16365

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Chitinase-3-Like Protein 1 as a Therapeutic Target for Inflammatory Diseases2025 · 8 citations
2Keratinocyte-derived CHI3L2 reprograms phospholipid metabolism to promote skin inflammation in psoriasisOriginal Research · 2026
3The emerging role of CHI3L1 as a diagnostic marker and therapeutic target in allergic diseases and respiratory comorbidities2024 · 7 citations
4Redefining CHI3L1: Therapeutic Opportunities at the Crossroads of Immune Suppression and Disease ProgressionReview · 2026
5Recently updated role of Chitinase 3-like 1 on various cell types as a major infuencer of chronic inflammation2024 · 9 citations

An anti-cell adhesion molecule 1 antibody improves mite antigen-induced atopic dermatitis-like lesions and pruritus in NC/Nga mice2026
Chitinase 3-Like 1 Promotes Endothelial-to-Mesenchymal Transition in Systemic Sclerosis via mTORC1 Signaling Pathway.2025
Temperature-Related Intensity Change (TRIC)-based High Throughput Screening Platform for the Discovery of CHI3L1-Targeted Small Molecules2025
Fluoxetine attenuates asthma symptoms in a murine model through modulation of innate and adaptive immune components, and regulation of ROR γ t signalling axis in a pathogenic Th17 cell populationBritish Journal of Pharmacology · 2026
GLP‐1 receptor activation attenuates chronic migraine‐like behaviour: Sex‐specific modulation of opioid‐ and endocannabinoid‐related pathwaysBritish Journal of Pharmacology · 2026

More from British Journal of Pharmacology

More from Kyungpook National University

More from Chungbuk National University

More from Mokpo National University

More from Osong Medical Innovation Foundation